Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Share-based Compensation (2016 - 2025)

Plus Therapeutics has reported Share-based Compensation over the past 16 years, most recently at $713000.0 for Q4 2025.

  • Quarterly Share-based Compensation rose 457.03% to $713000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2025, up 180.0% year-over-year, with the annual reading at $1.5 million for FY2025, 180.0% up from the prior year.
  • Share-based Compensation was $713000.0 for Q4 2025 at Plus Therapeutics, up from $527000.0 in the prior quarter.
  • Over five years, Share-based Compensation peaked at $713000.0 in Q4 2025 and troughed at $107000.0 in Q1 2021.
  • The 5-year median for Share-based Compensation is $146000.0 (2024), against an average of $198352.9.
  • Year-over-year, Share-based Compensation surged 791.67% in 2021 and then dropped 22.22% in 2023.
  • A 5-year view of Share-based Compensation shows it stood at $107000.0 in 2021, then grew by 21.5% to $130000.0 in 2022, then grew by 8.46% to $141000.0 in 2023, then dropped by 9.22% to $128000.0 in 2024, then surged by 457.03% to $713000.0 in 2025.
  • Per Business Quant, the three most recent readings for PSTV's Share-based Compensation are $713000.0 (Q4 2025), $527000.0 (Q3 2025), and $152000.0 (Q2 2025).